Statins and the Status Quo

I rather doubt you need me to bring the roiling statin debate to your attention, given its prominence in scientific circles and mass media alike. In essence, a new set of guidelines for the use of lipid-lowering drugs to prevent heart disease was issued with considerable fanfare, and then set off a firestorm of controversy.

The old approach relied heavily on levels of LDL cholesterol, while the new approach relies on a calculation of overall cardiac risk that leaves LDL out of the mix altogether. At stake are statin prescriptions for millions of us.

Read more:

https://www.linkedin.com/today/post/article/20131205140748-23027997-statins-static-and-the-status-quo-is-anyone-getting-the-signal?published=t?trk=object-title